thiazolyl blue has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argano, M; Buracco, P; De Maria, R; Menzies, MPL; Rodlsberger, K | 1 |
| Avanzo, JL; Caetano, HV; Dagli, ML; Fukumasu, H; Matera, JM; Matsuzaki, P; Nagamine, M; Pinello, KC; Silva, TC; Torres, LN | 1 |
| Balkman, CE; Engler, KL; Johnson, CS; Muindi, JR; Page, RL; Ramnath, N; Rassnick, KM; Trump, DL; Yu, WD | 1 |
1 trial(s) available for thiazolyl blue and Canine Diseases
| Article | Year |
|---|---|
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Calcitriol; Cell Line, Tumor; Cisplatin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Hypersensitivity; Gastrointestinal Diseases; Hematologic Diseases; Injections, Intravenous; Neoplasms; Tetrazolium Salts; Thiazoles; Vitamins | 2008 |
2 other study(ies) available for thiazolyl blue and Canine Diseases
| Article | Year |
|---|---|
Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Colorimetry; Coloring Agents; Dog Diseases; Dogs; Female; Hypnotics and Sedatives; Mammary Neoplasms, Animal; Propofol; Tetrazolium Salts; Thiazoles | 2019 |
In vitro chemosensitivity of canine mast cell tumors grades II and III to all-trans-retinoic acid (ATRA).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Male; Mast Cells; Mastocytosis; Tetrazolium Salts; Thiazoles; Tretinoin; Tumor Cells, Cultured | 2009 |